Evidence map›Paper›PMID 33915732›Full record

ArticleMolecules (Basel, Switzerland)2021

Involvement of Neuropeptide Galanin Receptors 2 and 3 in Learning, Memory and Anxiety in Aging Mice.

Felix Locker, Lara Bieler, Lioba M F Nowack, Julia Leitner, Susanne Maria Brunner, Pia Zaunmair, Barbara Kofler, Sebastien Couillard-Despres

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Felix LockerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0003-3487-362X
Lara BielerInstitute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-1197-0403
Lioba M F NowackInstitute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Julia LeitnerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria.
Susanne Maria BrunnerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-9623-1115
Pia ZaunmairInstitute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Barbara KoflerResearch Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Müllner Hauptstraße 48, 5020 Salzburg, Austria.ORCID 0000-0002-1198-4776
Sebastien Couillard-DespresInstitute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-8486-6412
Paracelsus Medical University · ATUniversity of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund F4413Österreichische Agentur für Internationale Mobilität und Kooperation in Bildung, Wissenschaft und Forschung HR02/2018Österreichische Forschungsförderungsgesellschaft 822782/THERAPEP
6 · The paper itself

Abstract

The neuropeptide galanin (GAL), which is expressed in limbic brain structures, has a strong impact on the regulation of mood and behavior. GAL exerts its effects via three G protein-coupled receptors (GAL

Indexed as

Disease SusceptibilityAge FactorsAgingAnimalsAnxietyBiomarkersDentate GyrusDisease Models, AnimalGene ExpressionImmunohistochemistryLearningMaze LearningMemoryMiceMice, KnockoutNeuropeptidesBiomarkersNeuropeptidesReceptor, Galanin, Type 2Receptor, Galanin, Type 3agingbehaviorgalaninknock-outlearningneuropeptide

Identifiers

PMID33915732
PMCPMC8037218
OpenAlexW3151940822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.